| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 816.929.377 $ | +572.226.490 $ | +364,8 % | 14 | 202.514.193 $ | -20.784.228 $ | +34,0 % | 5 | 249.079.919 $ | +139.099.315 $ | +130,5 % | 6 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 361.330.476 $ | +274.617.053 $ | +316,7 % | 1 | 86.713.423 $ | -39.371.217 $ | -31,2 % | 1 | 126.084.640 $ | +93.614.376 $ | +288,3 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 89.319.403 $ | +69.301.952 $ | +346,2 % | 1 | 20.017.451 $ | +7.317.497 $ | +57,6 % | 1 | 12.699.954 $ | +8.752.644 $ | +221,7 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Neutral | 87.236.001 $ | +26.089.539 $ | +42,7 % | 1 | 61.146.462 $ | -3.337.750 $ | -5,2 % | 1 | 64.484.212 $ | +25.485.720 $ | +65,4 % | 1 |
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 53.857.222 $ | +32.244.298 $ | +149,2 % | 1 | 21.612.924 $ | +11.885.309 $ | +122,2 % | 1 | ||||
| Perspective Therapeutics, Inc. | CATX | → 0 | Neutral | 48.823.492 $ | +39.993.976 $ | +453,0 % | 1 | ||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 32.172.000 $ | +30.011.380 $ | +1.389,0 % | 1 | ||||||||
| Context Therapeutics Inc. | CNTX | → 0 | Neutral | 24.891.370 $ | +16.799.233 $ | +207,6 % | 1 | ||||||||
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Schwach | 20.571.012 $ | +7.547.079 $ | +57,9 % | 1 | 13.023.933 $ | +2.721.933 $ | +26,4 % | 1 | ||||
| REPLIGEN CORP | RGEN | → 0 | Neutral | 18.370.914 $ | +10.128.756 $ | +122,9 % | 1 | ||||||||
| Medtronic plc | MDT | → 0 | Neutral | 16.762.000 $ | +6.425.944 $ | +62,2 % | 1 | 18.152.744 $ | +18.152.744 $ | 1 | |||||
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Neutral | 17.707.900 $ | +15.687.769 $ | +776,6 % | 1 | ||||||||
| Aktis Oncology, Inc. | AKTS | → 0 | Neutral | 17.168.259 $ | +17.168.259 $ | 1 | |||||||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 16.040.609 $ | -18.523.929 $ | -53,6 % | 1 | ||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 14.838.150 $ | +14.838.150 $ | 1 | |||||||||
| IMMUNIC, INC. | IMUX | → 0 | Schwach | 13.881.178 $ | +11.373.102 $ | +453,5 % | 1 | ||||||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 11.617.760 $ | +11.617.760 $ | 1 | |||||||||
| 816.929.377 $ | +572.226.490 $ | +364,8 % | 14 | 202.514.193 $ | -20.784.228 $ | +34,0 % | 5 | 249.079.919 $ | +139.099.315 $ | +130,5 % | 6 | ||||